News Releases

Date Title  
07/16/20
TORONTO , July 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, today reported preliminary revenue results for the three months ended June 30, 2020 . Management Commentary: “While our second quarter
07/01/20
Venus Viva MD is a new skin rejuvenation solution with differentiated features that allow clinicians in the traditional medical aesthetics community to treat a wider range of skin conditions TORONTO , July 01, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”)  (NASDAQ:
06/26/20
TORONTO , June 26, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”)  (NASDAQ: VERO ), a global medical aesthetic technology leader, announced today that the Company has been added to the Russell 2000 ® , Russell 3000 ® and Russell Microcap ® Indexes.
06/25/20
TORONTO , June 25, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced that second quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, August 13, 2020
06/16/20
TORONTO , June 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”)  (NASDAQ: VERO ), a global medical aesthetic technology leader, today announced that it has entered into a common stock purchase agreement for up to $31 million with Lincoln Park Capital Fund, LLC
06/15/20
Venus Epileve is a new, cost-effective, laser hair removal solution designed for customers in the aesthetics market TORONTO , June 15, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”)  (NASDAQ: VERO ), a global medical aesthetic technology leader, today announced that
05/14/20
TORONTO , May 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2020 . The Company notes that the financial results provided for the
04/15/20
TORONTO , April 15, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, May 14, 2020 .
03/30/20
TORONTO , March 30, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the three
03/18/20
TORONTO , March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible preferred
03/10/20
TORONTO , March 10, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30 .
03/03/20
Chad A. Zaring, Appointed Chief Commercial Officer TORONTO , March 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO ), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A.
02/14/20
CE Mark Approval for Venus Bliss ™️ for Non-Invasive Lipolysis of Abdomen & Flanks, Skin Tightening, Circumferential Reduction and Cellulite Reduction Health Canada License to Market NeoGraft 2.0 for hair restoration TORONTO , Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc.
01/13/20
TORONTO , Jan. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“ Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary unaudited revenue results for the three months and twelve months ended December 31, 2019 and introduced